Insider trades

Julie Rubinstein, COO of Adaptive Biotechnologies ADPT, has filed 0 purchases and 52 sales on the open market. Over the past 12 months that comes to a net sale of $13.4M. The latest trade was on 04/27.

Julie Rubinstein

President and COO
First filing
23/03/08
Trades
155 trades
Buys / sales
0 / 52
12-month net buying
−$13.4M
Last trade
04/27

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan04/2704/2919,037 sh$14.23$270,896.51−4.8%
ADPT
Open-market sale10b5-1 plan04/22–04/2404/2457,180 sh3 trades$13.96avg.$798,423.4−13.0%
ADPT
Open-market sale10b5-1 plan04/17–04/2104/2169,061 sh3 trades$14.60avg.$1,008,622.26−14.9%
ADPT
Open-market sale10b5-1 plan04/14–04/1604/1657,180 sh3 trades$14.45avg.$826,251−12.3%
ADPT
Open-market sale10b5-1 plan04/09–04/1304/1357,180 sh6 trades$13.26avg.$758,108.34−12.0%
ADPT
Open-market sale10b5-1 plan04/06–04/0804/0869,061 sh4 trades$14.34avg.$990,503.43−13.7%
ADPT
Open-market sale10b5-1 plan04/01–04/0204/0238,120 sh2 trades$14.53avg.$553,693−7.9%
ADPT
Open-market sale10b5-1 plan03/27–03/3103/3157,180 sh4 trades$13.14avg.$751,302.98−11.1%
ADPT
Open-market sale10b5-1 plan03/24–03/2603/2657,180 sh3 trades$14.03avg.$802,235.4−10.9%
ADPT
Open-market sale10b5-1 plan03/19–03/2303/2357,180 sh3 trades$13.46avg.$769,642.8−10.6%
ADPT
Open-market sale10b5-1 plan03/16–03/1803/1857,180 sh3 trades$13.33avg.$762,209.4−10.4%
ADPT
Open-market sale10b5-1 plan03/11–03/1303/13179,703 sh5 trades$13.21avg.$2,374,058.11−26.1%
ADPT
Open-market sale10b5-1 plan03/06–03/1003/1081,342 sh3 trades$14.90avg.$1,211,736.93−11.2%
ADPT
Open-market sale10b5-1 plan03/03–03/0503/0592,823 sh4 trades$16.09avg.$1,493,427.81−13.9%
ADPT
Open-market sale25/03/0525/03/0659,505 sh2 trades$6.98avg.$415,539.51−9.2%
ADPT
Open-market sale24/03/0524/03/0639,070 sh2 trades$3.47avg.$135,763.8−7.6%
Open-market sale23/03/0623/03/0822,668 sh$8.57$194,264.76−6.3%